These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 7967905)

  • 1. Alterations in the mucosal immune system in ulcerative colitis and Crohn's disease.
    MacDermott RP
    Med Clin North Am; 1994 Nov; 78(6):1207-31. PubMed ID: 7967905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoglobulin G (IgG), IgG1, and IgG2 determinations from endoscopic biopsy specimens in control, Crohn's disease, and ulcerative colitis subjects.
    Rüthlein J; Ibe M; Burghardt W; Mössner J; Auer IO
    Gut; 1992 Apr; 33(4):507-12. PubMed ID: 1582596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intestinal immune reactivity to interleukin 2 differs among Crohn's disease, ulcerative colitis, and controls.
    Kusugami K; Youngman KR; West GA; Fiocchi C
    Gastroenterology; 1989 Jul; 97(1):1-9. PubMed ID: 2785943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn's disease.
    Sartor RB
    Gastroenterol Clin North Am; 1995 Sep; 24(3):475-507. PubMed ID: 8809232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucosal imbalance of IL-1 and IL-1 receptor antagonist in inflammatory bowel disease. A novel mechanism of chronic intestinal inflammation.
    Casini-Raggi V; Kam L; Chong YJ; Fiocchi C; Pizarro TT; Cominelli F
    J Immunol; 1995 Mar; 154(5):2434-40. PubMed ID: 7868909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Changes in the immune system of the gastrointestinal tract in Crohn disease].
    Voss A; Steffen M
    Immun Infekt; 1990 Aug; 18(4):111-4. PubMed ID: 2210792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune responses triggering colitis and colitis-associated carcinoma.
    Kesselring R; Fichtner-Feigl S
    Langenbecks Arch Surg; 2012 Apr; 397(4):527-33. PubMed ID: 22382701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of interleukin-2-producing intestinal CD4+ T cells in inflammatory bowel disease.
    Kusugami K; Matsuura T; West GA; Youngman KR; Rachmilewitz D; Fiocchi C
    Gastroenterology; 1991 Dec; 101(6):1594-605. PubMed ID: 1683326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Overview of the Innate and Adaptive Immune System in Inflammatory Bowel Disease.
    Choy MC; Visvanathan K; De Cruz P
    Inflamm Bowel Dis; 2017 Jan; 23(1):2-13. PubMed ID: 27779499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysregulation of mucosal immune response in pathogenesis of inflammatory bowel disease.
    Xu XR; Liu CQ; Feng BS; Liu ZJ
    World J Gastroenterol; 2014 Mar; 20(12):3255-64. PubMed ID: 24695798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteria.
    Macpherson A; Khoo UY; Forgacs I; Philpott-Howard J; Bjarnason I
    Gut; 1996 Mar; 38(3):365-75. PubMed ID: 8675088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting immune cell circuits and trafficking in inflammatory bowel disease.
    Neurath MF
    Nat Immunol; 2019 Aug; 20(8):970-979. PubMed ID: 31235952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical analysis of the distribution of measles related antigen in the intestinal mucosa in inflammatory bowel disease.
    Iizuka M; Chiba M; Yukawa M; Nakagomi T; Fukushima T; Watanabe S; Nakagomi O
    Gut; 2000 Feb; 46(2):163-9. PubMed ID: 10644308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An immunofluorescence study of the intestinal mucosa in ulcerative colitis and Crohn's disease.
    Green FH; Fox H
    J Pathol; 1973 Jul; 110(3):Pii. PubMed ID: 4582851
    [No Abstract]   [Full Text] [Related]  

  • 15. Proceedings: A study by immunofluorescence of the intestinal mucosa in ulcerative colitis and Crohn's disease.
    Green FH; Fox H
    J Med Microbiol; 1973 Nov; 6(4):P18. PubMed ID: 4587399
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunoregulatory function of human intestinal mucosa lymphoid cells: evidence for enhanced suppressor cell activity in inflammatory bowel disease.
    Fiocchi C; Youngman KR; Farmer RG
    Gut; 1983 Aug; 24(8):692-701. PubMed ID: 6223862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor Necrosis Factor and Lymphotoxin in Regulation of Intestinal Inflammation.
    Gubernatorova EO; Tumanov AV
    Biochemistry (Mosc); 2016 Nov; 81(11):1309-1325. PubMed ID: 27914457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chronic inflammatory bowel diseases (IBD): novel pathophysiological concepts and their clinical relevance].
    Stange EF; Schmid M; Fellermann K; Wehkamp J
    Praxis (Bern 1994); 2005 Sep; 94(37):1429-32. PubMed ID: 16193905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Old and New Lymphocyte Players in Inflammatory Bowel Disease.
    Giuffrida P; Corazza GR; Di Sabatino A
    Dig Dis Sci; 2018 Feb; 63(2):277-288. PubMed ID: 29275447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crohn's disease, ulcerative colitis, and normal intestinal lymphocytes express integrins in dissimilar patterns.
    Yacyshyn BR; Lazarovits A; Tsai V; Matejko K
    Gastroenterology; 1994 Nov; 107(5):1364-71. PubMed ID: 7523224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.